[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-335129-105":59,"doc-detail-335129-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","age-specific-differences-in-breast-cancer-treatment-between-screen-detected-and-non-screen-detected-breast-cancers-in-women-aged-4074-years-at-diagnosis-in-sweden-20082017-short-report","Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017 - short report","","Screening-detected invasive breast cancers previously showed more favourable tumour features than non-screen-detected cancers; this study evaluates whether treatment differs by age at diagnosis. Nationwide register data (Sweden, 2008–2017) from the National Quality Register for Breast Cancer compare screen-detected versus non-screen-detected cases using multivariable logistic regression with adjustment for tumour (T) and nodal (N) status. Significant treatment disparities persist across ages, with less aggressive patterns among screened cases, except for endocrine therapy and surgery-adjusted radiotherapy effects.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/age-specific-differences-in-breast-cancer-treatment-between-screen-detected-and-non-screen-detected-breast-cancers-in-women-aged-4074-years-at-diagnosis-in-sweden-20082017-short-report/335129/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/age-specific-differences-in-breast-cancer-treatment-between-screen-detected-and-non-screen-detected-breast-cancers-in-women-aged-4074-years-at-diagnosis-in-sweden-20082017-short-report/335129.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What is the objective of the study?","Question",{"text":112,"@type":113},"To analyze differences in breast cancer treatment between screen-detected and non-screen-detected cases by age at diagnosis, with and without adjustment for tumour (T) and nodal (N) status.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were treatment differences estimated?",{"text":117,"@type":113},"Data from Sweden’s National Quality Register for Breast Cancer (2008–2017) were analyzed using multivariable logistic regression to calculate odds ratios and 95% confidence intervals for treatment disparities.",{"name":119,"@type":110,"acceptedAnswer":120},"What treatment differences were observed between screen-detected and non-screen-detected cases?",{"text":121,"@type":113},"Screen-detected cases were more likely to receive partial mastectomy and were less likely to receive chemotherapy and antibody therapy. After adjusting for surgery type, screen-detected cases showed lower likelihoods of radiotherapy.",{"name":123,"@type":110,"acceptedAnswer":124},"Do tumour (T) and nodal (N) status explain the observed disparities?",{"text":125,"@type":113},"No. Adjusting for T and N did not alter the main patterns, indicating these factors cannot solely explain the treatment differences by screening status.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},335129,1790723495,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":24,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":148,"preview_page_count":4},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","SHORT REPORT  \nAge-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017  \nHåkan Jonssona,b, Anne Anderssona, Zheng Maoa and Lennarth Nyströmb  \na Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden; bDepartment of Epidemiology and Global Health, Umeå University, Umeå, Sweden  \nABSTRACT  \nBackground and purpose: We have recently demonstrated that screen-detected invasive breast cancers had more favourable tumour characteristics than non-screen-detected. The objective of the study was to analyse differences in breast cancer treatment between screen-detected and non-screen-detected cases by age at diagnosis, with and without adjustment for tumour (T) and nodal (N) status, within a nationwide, population-based mammography screening programme utilising register data.  \nMaterial and methods: Data spanning 2008–2017 were collected from the National Quality Register for Breast Cancer. Multivariable logistic regression analysis was used to estimate odds ratios and 95% confidence intervals for treatment disparities between screen-detected and non-screen-detected breast cancer. Results: Among 46,481 women diagnosed with invasive breast cancer aged 40–74 and invited for mammography screening, significant differences in treatment were observed. Screen-detected cases showed higher likelihoods of partial mastectomy compared to mastectomy, endocrine therapy, and radiotherapy, whereas chemotherapy and antibody therapy were less likely compared to non-screen-detected cases. However, when adjusting for surgery type, screen-detected cases showed lower likelihoods of radiotherapy. Age at diagnosis significantly influenced treatment odds ratios, with interactions observed for all treatments except radiotherapy adjusted for surgery. Differences increased with age, except for endocrine therapy. Radiotherapy adjusted for surgery type showed no age-related interaction. Adjusting for T and N did not alter these patterns.  \nInterpretation: In general, screen-detected cases received less aggressive treatment, such as mastectomy, chemotherapy, and antibody therapy, compared to non-screen-detected cases. Disparities increased with age, except for endocrine therapy and radiotherapy adjusted for surgery. Differences persisted after adjusting forT and N, suggesting that these factors cannot solely explain the results.  \nARTICLE HISTORY  \nReceived 29 February 2024 Accepted 19 June 2024 Published 5 July 2024  \nKEYWORDS  \nBreast cancer;  \nscreening programme; mammography;  \nsurgery; chemotherapy; radiotherapy; endocrine therapy; antibody therapy  \nIntroduction  \nAccording to the national cancer and cause of death register in Sweden, in 2021, 8,619 women were diagnosed with breast cancer and 1,326 women died with breast cancer as the underlying cause of death [1] .  \nOverviews and meta-analysis of the randomised controlled trials on mammography screening have shown that breast cancer screening with mammography can reduce the mortality from breast cancer for women aged 50–69 years with 20%–25%[2–4].  \nIn 1986, the National Board of Health and Welfare in Sweden recommended the county councils to invite women aged 40–74 years to mammography screening. The programme was fully implemented in all 21 counties in 1997 for the 50–69-year age group and in 2012 for the 40–49 and 70–74-year age groups.  \nSeveral small studies in Finland, Italy, Japan, Sweden and the UK have compared treatment modalities between screen-  \ndetected and non-screen-detected breast cancer cases. Screendetected women had a higher proportion of partial mastectomy (conservative surgery) (three studies) [5–7], a lower proportion of chemotherapy (three studies) [6–8], a higher proportion of endocrine therapy (one study) [6], and a lower proportion of adjuvant systemic therapy (two studies) [9, 10] . However, in all, except two, studies with recent data [5, 6], all o","cbCaipBzArFcMLYn","https://ap.wps.com/l/cbCaipBzArFcMLYn","pdf",187467,"English","# Abstract\n## Background and purpose\n## Material and methods\n## Results\n## Interpretation\n# Introduction\n## Screening recommendations and programme rollout\n## Rationale for evaluating age-specific treatment differences\n# Material and methods\n## Data retrieval\n# Keywords\n# Article information","[{\"question\":\"What is the objective of the study?\",\"answer\":\"To analyze differences in breast cancer treatment between screen-detected and non-screen-detected cases by age at diagnosis, with and without adjustment for tumour (T) and nodal (N) status.\"},{\"question\":\"How were treatment differences estimated?\",\"answer\":\"Data from Sweden’s National Quality Register for Breast Cancer (2008–2017) were analyzed using multivariable logistic regression to calculate odds ratios and 95% confidence intervals for treatment disparities.\"},{\"question\":\"What treatment differences were observed between screen-detected and non-screen-detected cases?\",\"answer\":\"Screen-detected cases were more likely to receive partial mastectomy and were less likely to receive chemotherapy and antibody therapy. After adjusting for surgery type, screen-detected cases showed lower likelihoods of radiotherapy.\"},{\"question\":\"Do tumour (T) and nodal (N) status explain the observed disparities?\",\"answer\":\"No. Adjusting for T and N did not alter the main patterns, indicating these factors cannot solely explain the treatment differences by screening status.\"}]","Age-specific differences in breast cancer treatment between screen-detected and non-screen-detected breast cancers in women aged 40–74 years at diagnosis in Sweden 2008–2017 - short report | PDF",1790009753,13]